Haseltine Gets Down and Dirty with Biology | GenomeWeb

William Haseltine is a party pooper.  

While others are celebrating the near completion of a working draft of the human genome, Haseltine, chairman and CEO of Human Genome Sciences (Nasdaq: HGSI) dismissed the accomplishment as more conceptual than scientific. 

“The human genome, from my point of you,” said Haseltine, “is not useful for medicine.” 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."